{"id":"https://openalex.org/W1998845488","doi":"https://doi.org/10.1007/bf01901433","title":"2,6-Dichlorobenzylidene amino guanidine acetate (Wy-8678). A new hypotensive agent","display_name":"2,6-Dichlorobenzylidene amino guanidine acetate (Wy-8678). A new hypotensive agent","publication_year":1969,"publication_date":"1969-10-01","ids":{"openalex":"https://openalex.org/W1998845488","doi":"https://doi.org/10.1007/bf01901433","mag":"1998845488","pmid":"https://pubmed.ncbi.nlm.nih.gov/5357105"},"language":"pl","primary_location":{"id":"doi:10.1007/bf01901433","doi":"https://doi.org/10.1007/bf01901433","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf01901433","pdf_url":null,"source":{"id":"https://openalex.org/S60362788","display_name":"Cellular and Molecular Life Sciences","issn_l":"1420-682X","issn":["1420-682X","1420-9071"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experientia","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070725191","display_name":"Thomas H. Baum","orcid":"https://orcid.org/0000-0002-4574-5212","observed_orcids":["https://orcid.org/0000-0002-4574-5212"]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Baum","raw_affiliation_strings":["Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., 19087, Radnor, Pennsylvania, USA","Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., Radnor, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., 19087, Radnor, Pennsylvania, USA","institution_ids":["https://openalex.org/I4403928396"]},{"raw_affiliation_string":"Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., Radnor, USA","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003255382","display_name":"Donald K. Eckfeld","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. K. Eckfeld","raw_affiliation_strings":["Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., 19087, Radnor, Pennsylvania, USA","Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., Radnor, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., 19087, Radnor, Pennsylvania, USA","institution_ids":["https://openalex.org/I4403928396"]},{"raw_affiliation_string":"Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., Radnor, USA","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013501096","display_name":"N. K. Metz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N. Metz","raw_affiliation_strings":["Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., 19087, Radnor, Pennsylvania, USA","Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., Radnor, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., 19087, Radnor, Pennsylvania, USA","institution_ids":["https://openalex.org/I4403928396"]},{"raw_affiliation_string":"Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., Radnor, USA","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032405656","display_name":"Joe L. Dinish","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. L. Dinish","raw_affiliation_strings":["Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., 19087, Radnor, Pennsylvania, USA","Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., Radnor, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., 19087, Radnor, Pennsylvania, USA","institution_ids":["https://openalex.org/I4403928396"]},{"raw_affiliation_string":"Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., Radnor, USA","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079602576","display_name":"Gary Rowles","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Rowles","raw_affiliation_strings":["Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., 19087, Radnor, Pennsylvania, USA","Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., Radnor, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., 19087, Radnor, Pennsylvania, USA","institution_ids":["https://openalex.org/I4403928396"]},{"raw_affiliation_string":"Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., Radnor, USA","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017139185","display_name":"RONALD VAN PELT","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. van Pelt","raw_affiliation_strings":["Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., 19087, Radnor, Pennsylvania, USA","Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., Radnor, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., 19087, Radnor, Pennsylvania, USA","institution_ids":["https://openalex.org/I4403928396"]},{"raw_affiliation_string":"Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., Radnor, USA","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059460319","display_name":"Allen T. Shropshire","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. T. Shropshire","raw_affiliation_strings":["Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., 19087, Radnor, Pennsylvania, USA","Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., Radnor, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., 19087, Radnor, Pennsylvania, USA","institution_ids":["https://openalex.org/I4403928396"]},{"raw_affiliation_string":"Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., Radnor, USA","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":null,"display_name":"S. P. Fernandez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. P. Fernandez","raw_affiliation_strings":["Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., 19087, Radnor, Pennsylvania, USA","Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., Radnor, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., 19087, Radnor, Pennsylvania, USA","institution_ids":["https://openalex.org/I4403928396"]},{"raw_affiliation_string":"Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., Radnor, USA","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051624295","display_name":"Melvyn I. Gluckman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. I. Gluckman","raw_affiliation_strings":["Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., 19087, Radnor, Pennsylvania, USA","Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., Radnor, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., 19087, Radnor, Pennsylvania, USA","institution_ids":["https://openalex.org/I4403928396"]},{"raw_affiliation_string":"Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., Radnor, USA","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045877804","display_name":"William F. Bruce","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. F. Bruce","raw_affiliation_strings":["Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., 19087, Radnor, Pennsylvania, USA","Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., Radnor, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., 19087, Radnor, Pennsylvania, USA","institution_ids":["https://openalex.org/I4403928396"]},{"raw_affiliation_string":"Pharmacological Evaluation and Organic Medicinal Chemistry Sections, Wyeth Laboratories, Inc., Radnor, USA","institution_ids":["https://openalex.org/I4403928396"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4403928396"],"apc_list":{"value":4290,"currency":"USD","value_usd":4290},"apc_paid":null,"fwci":0.5752,"has_fulltext":false,"cited_by_count":26,"citation_normalized_percentile":{"value":0.67522091,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"25","issue":"10","first_page":"1066","last_page":"1067"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antihypertensive-drugs","display_name":"antihypertensive drugs","score":0.8640000224113464},{"id":"https://openalex.org/keywords/antihypertensive-effect","display_name":"antihypertensive effect","score":0.9319999814033508},{"id":"https://openalex.org/keywords/experimental-hypertension-models","display_name":"experimental hypertension models","score":0.7509999871253967},{"id":"https://openalex.org/keywords/blood-pressure-reduction","display_name":"blood pressure reduction","score":0.8640000224113464},{"id":"https://openalex.org/keywords/guanidine-derivatives","display_name":"guanidine derivatives","score":0.7699999809265137}],"concepts":[{"id":"https://openalex.org/C2779463914","wikidata":"https://www.wikidata.org/wiki/Q183309","display_name":"Guanidine","level":2,"score":0.6541466116905212},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5363465547561646},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37427663803100586},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3329400420188904},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2852531671524048},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22733160853385925},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1883470118045807}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006145","descriptor_name":"Guanethidine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006146","descriptor_name":"Guanidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006146","descriptor_name":"Guanidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006339","descriptor_name":"Heart Rate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006830","descriptor_name":"Hydralazine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008750","descriptor_name":"Methyldopa","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012110","descriptor_name":"Reserpine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/bf01901433","doi":"https://doi.org/10.1007/bf01901433","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf01901433","pdf_url":null,"source":{"id":"https://openalex.org/S60362788","display_name":"Cellular and Molecular Life Sciences","issn_l":"1420-682X","issn":["1420-682X","1420-9071"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experientia","raw_type":"journal-article"},{"id":"pmid:5357105","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/5357105","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experientia","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2240727753","https://openalex.org/W2413250485","https://openalex.org/W2410424844","https://openalex.org/W2433804665","https://openalex.org/W2085111713","https://openalex.org/W2471347603","https://openalex.org/W614781491","https://openalex.org/W2434276266","https://openalex.org/W2413273307","https://openalex.org/W3102451470"],"abstract_inverted_index":null,"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}